ArticleEuropean radiology2021

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict chemotherapeutic responses and survival in primary central-nervous-system lymphoma.

Fan Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.